간경변 환자에서 콜히친 사용에 의한 호중구성 백혈구감소증 1예
A Case of Colchicine-Induced Neutropenia in Liver Cirrhosis Patient
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Colchicine is an alkaloid that has been used for treating acute gouty arthritis, psoriasis, scleroderma and Behcet's syndrome. Colchicine decreased liver fibrosis in rats with carbon tetrachloride induced cirrhosis and in patients with many liver diseases. Therapeutic oral doses of colchicine may cause nausea, vomiting, abdominal pain and diarrhea. The adverse effect of colchicine associated with the dose is bone marrow suppression, and especially neutopenia. Neutropenia has often been reported in patients have taken an overdose of colchicine. We describe a 64-year-old female liver cirrhosis patient with neutropenia that was induced by a therapeutic dose of colchicine.
Abstract
Colchicine is an alkaloid that has been used for treating acute gouty arthritis, psoriasis, scleroderma and Behcet's syndrome. Colchicine decreased liver fibrosis in rats with carbon tetrachloride induced cirrhosis and in patients with many liver diseases. Therapeutic oral doses of colchicine may cause nausea, vomiting, abdominal pain and diarrhea. The adverse effect of colchicine associated with the dose is bone marrow suppression, and especially neutopenia. Neutropenia has often been reported in patients have taken an overdose of colchicine. We describe a 64-year-old female liver cirrhosis patient with neutropenia that was induced by a therapeutic dose of colchicine.
참고문헌 (13)
- Ben-Chetrit E, "Colchicine: 1998 update", Semin Arthritis Rheum, 28(1), pp.48~59 (1998)
- Nava-Ocampo AA, "Effect of colchiceine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver histology in experimentally induced carbon tetrachloride cirrhosis in rats", Eur J Clin Invest, 27(1), pp.77~84 (1997)
- Kershenobich D, "Colchicine in the treatment of cirrhosis of the liver", N Engl J Med, 318(26), pp.1709~1713 (1988)
- Levy M, "Colchicine: a state-of-the-art review", Pharmacotherapy, 11(3), pp.196~211 (1991)
- Putterman C, "Colchicine intoxication: clinical pharmacology, risk factors, features, and management", Semin Arthritis Rheum, 21(3), pp.143~155 (1991)
- Ehrlich HP, "Microtubules in transcellular movement of procollagen", Nat New Biol, 238(87), pp.257~260 (1972)
- Maxwell MJ, "Accidental colchicine overdose. A case report and literature review", Emerg Med J, 19(13), pp.265~267 (2002)
- Neuss MN, "Long-term colchicine admini- stration leading to colchicine toxicity and death", Arthritis Rheum, 29(3), pp.448~449 (1986)
- Dixon AJ, "Probable colchicine-induced neutropenia not related to intentional overdose", Ann Pharmacother, 35(2), pp.192~195 (2001)
- Katz R, "Use of granulocyte colony-stimulating factor in the treatment of pancytopenia secondary to colchicine overdose", Ann Pharmacother, 26(9), pp.1087~1088 (1992)
- Morgan TR, "Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival", Gastroenterology, 128(4), pp.882~890 (2005)
- Rambaldi A, "Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis", Liver, 20(3), pp.262~266 (2000)
- Arrieta O, "Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis vgirus-related liver cirrhosis", Cancer, 107(8), pp.1852~1858 (2006)